Institute of Biomedicine
- Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register (2023)
- Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2018)
- Identification of natural peptides from "PlantPepDB" database as anti-SARS-CoV-2 agents: A protein-protein docking approach (2023)
- Identification of NCAN as a candidate gene for developmental dyslexia (2017)
- Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort (2018)
- Identification of novel genes involved in the pathophysiology of adrenocortical
tumorigenesis (2017) - Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in over 140,000 European Descendants (2019)
- Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases (2021)
- Identification of predictive ERBB mutations for targeted treatment (2023)
- Identification of rare wnt1 osteoporosis patient (2017)



